Alan Todd Roth - 03 Feb 2026 Form 4 Insider Report for REGENCY CENTERS CORP (REG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Feb 2026, 14:38:10 UTC
Prior SEC filing
13 Feb 2025
Next SEC filing
11 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Michael R. Herman Attorney-in-Fact

Key filing fact

Alan Todd Roth filed Form 4 for REGENCY CENTERS CORP (REG) on 05 Feb 2026.

Key facts

  • This page summarizes Alan Todd Roth's Form 4 filing for REGENCY CENTERS CORP (REG).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 05 Feb 2026, 14:38.

Change

  • Previous filing in this sequence was filed on 13 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001662980 Primary reporting owner

ROTH ALAN TODD

Relationship
E. Regional Pres. & COO
Address
C/O REGENCY CENTERS CORPORATION, ONE INDEPENDENT DRIVE SUITE 114, JACKSONVILLE
Signature
/s/Michael R. Herman Attorney-in-Fact
Signature date
05 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REG transaction Derivative

Restricted Stock Grant

Award

Transaction value
$0
Shares
+4,414
Change %
Price
$0.000000
Shares after
4,414
Date
03 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,414
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares vest 25% per year beginning February 3, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .